论文部分内容阅读
曲妥珠单抗trastuzumab商品名:赫赛汀(Herceptin)研制公司:罗氏制药公司Herceptin新增适应证为与芳香酶抑制剂联合使用用于绝经妇女雌激素受体(ER)阳性或孕激素受体(PgR)阳性的转移性乳腺癌。Herceptin与芳香酶抑制剂联合用药是首个含两种靶向疗法并获得欧盟首肯的,在3期TAnDEM
Trastuzumab Trastuzumab Name of Product: Herceptin Development Company: Herceptin, Roche Pharmaceuticals New Indications for Use with Aromatase Inhibitors for Estrogen Receptor (ER) -positive or Progesterone-Derived In Postmenopausal Women Body (PgR) positive metastatic breast cancer. Herceptin and aromatase inhibitor combination therapy is the first with two targeted therapies and get the EU approval, in the third stage TAnDEM